Cigarette smoking and rheumatoid arthritis*,**

https://doi.org/10.1053/sarh.2001.27719Get rights and content

Abstract

Objectives: To examine and explore the potential relationships among the following: the incidence/severity of rheumatoid arthritis (RA), the extra-articular manifestations of RA, vascular disease, certain specific malignancies, the p53 tumor suppressor gene, and cigarette smoking. Methods: The medical literature was reviewed from 1985 to 2001 with the assistance of a MEDLINE search using the key words vascular disease, smoking, protein p53, RA, rheumatoid vasculitis, cancer, and malignancies. A qualitative review was performed after all articles were abstracted and new information summarized. Results: Cigarette smoking has been increasingly shown in epidemiologic and case-control studies to be an important risk factor for both the incidence and severity of RA, especially in seropositive men. Further, there is evidence of a downward trend in incidence of extra-articular manifestations of RA, especially RA vasculitis, observed with a decrease in worldwide tobacco use and overall improved mortality in RA. The association of cigarette smoking with lung and other cancers and its link to vascular disease (including Buerger's disease) and atherosclerosis appears secure. Mutations or alterations in p53, a suppressor gene that regulates cell growth, have been found in certain cancers, cigarette smokers, and in patients with RA. Conclusions: Cigarette smoking appears to have an undeniable link to the pathogenesis of vascular disease of many types, including the possibility of a strong causal connection to rheumatoid vasculitis. The observations worldwide of decreasing tobacco use along with secular trends of diminished RA vasculitis and extra-articular manifestations, and with improved survival, points to a better outcome for our patients. The example of p53 may be a first step in the discovery of additional links between environmental triggers and phenotypic expression of chronic illness. Semin Arthritis Rheum 31:146-159. Copyright © 2001 by W.B. Saunders Company

Section snippets

Methods

The hypothesis for this review was the potential existence of a relationship among RA, vascular disease, smoking, p53, and malignancy. Therefore, a MEDLINE and PubMed search of the medical literature was carried out with the key words and MESH headings of rheumatoid arthritis, smoking, vascular disease, vasculitis, rheumatoid vasculitis, malignancy, protein p53, and cancer. A qualitative review of the articles obtained was undertaken, and each paper was examined for possible relationships

Gene p53 and cancer

The p53 tumor suppressor gene encodes a 53 kDa nuclear phosphoprotein that plays a major role in the synthesis, repair, and apoptotic functions of the cell cycle 11, 29. These mechanisms have likely evolved to maintain the stability of the genome during cellular stress from DNA damage, hypoxia, and activated oncogenes. When cellular DNA is damaged, the p53 protein arrests growth at the G1/S interface until the damage is repaired. Alternatively, p53 will induce apoptosis if damage is severe (30)

Discussion

The undeniable role cigarette smoking plays in the pathogenesis of vascular disease and cancer has paved the way for its recognition as a risk factor for either incidence or severity in RA. Figure 1 symbolizes potential interrelationships among smoking and various individual molecular mechanisms and disease processes.

. Hypothetical relationships with cigarette smoking among disease expression, molecular mechanisms, and disease pathogenesis.

Damage induced by NO, oxygen radicals, and carbon

References (119)

  • JD Mathews et al.

    Association of autoantibodies with smoking, cardiovascular morbidity, and death in the Busselton population

    Lancet

    (1973)
  • TD Spector et al.

    Effect of cigarette smoking on Langerhans' cells

    Lancet

    (1988)
  • GS Tell et al.

    Risk factors for site specific extracranial carotid artery plaque distribution as measured by B-mode ultrasound

    J Clin Epidemiol

    (1989)
  • SE Barrow et al.

    Cigarette smoking: profiles of thromboxane- and prostacyclin-derived products in human urine

    Biochim Biophys Acta

    (1989)
  • DD Blache et al.

    Acute influence of smoking on platelet behaviour, endothelium and plasma lipids and normalization by aspirin

    Atherosclerosis

    (1992)
  • RK Saetzler et al.

    Polynitroxylated hemoglobin-based oxygen carrier: inhibition of free radical-induced microcirculatory dysfunction

    Free Radic Biol Med

    (1999)
  • S. Shionoya

    Diagnostic criteria of Buerger's disease

    Int J Cardiol

    (1998)
  • M Kobayashi et al.

    Immunohistochemical analysis of arterial wall cellular infiltration in Buerger's disease (endarteritis obliterans)

    J Vasc Surg

    (1999)
  • S Sasaki et al.

    Current trends in thromboangiitis obliterans (Buerger's disease) in women

    Am J Surg

    (1999)
  • J Eichhorn et al.

    Antiendothelial cell antibodies in thromboangiitis obliterans

    Am J Med Sci

    (1998)
  • BJ Harrison et al.

    Does smoking influence disease outcome in patients with rheumatoid arthritis?

    J Rheumatol

    (2000)
  • W. Telleson

    Rheumatoid pneumoconiosis (Caplan's syndrome) in an asbestos worker

    Thorax

    (1961)
  • F. Wolfe

    The effect of smoking on clinical, laboratory, and radiographic status in rheumatoid arthritis

    J Rheumatol

    (2000)
  • PA Bacon et al.

    Extra-articular rheumatoid arthritis.

  • A. Caplan

    Certain unusual radiological appearances in the chest of coal-miners suffering from rheumatoid arthritis

    Thorax

    (1953)
  • M Klockars et al.

    Silica exposure and rheumatoid arthritis: a follow-up study of granite workers 1940-81

    Br Med J Clin Res Ed

    (1987)
  • CM Weyand et al.

    The influence of sex on the phenotype of rheumatoid arthritis

    Arthritis Rheum

    (1998)
  • MS Greenblatt et al.

    Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis

    Cancer Res

    (1994)
  • M Ramet et al.

    p53 protein expression is correlated with benzo[a]pyrene-DNA adducts in carcinoma cell lines

    Carcinogenesis

    (1995)
  • E Ernst et al.

    Dose-effect relationship between smoking and blood rheology

    Br J Haematol

    (1987)
  • JW Davis et al.

    Effects of tobacco and non-tobacco cigarette smoking on endothelium and platelets

    Clin Pharmacol Ther

    (1985)
  • AH Henderson et al.

    Endothelium in control

    Br Heart J

    (1991)
  • DS Celermajer et al.

    Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults

    Circulation

    (1993)
  • M Papa et al.

    Autoimmune mechanisms in thromboangiitis obliterans (Buerger's disease): the role of tobacco antigen and the major histocompatibility complex

    Surgery

    (1992)
  • GS Firestein et al.

    Somatic mutations in the p53 tumor suppressor gene in rheumatoid arthritis synovium

    Proc Natl Acad Sci U S A

    (1997)
  • KG Saag et al.

    Rheumatoid arthritis lung disease. Determinants of radiographic and physiologic abnormalities

    Arthritis Rheum

    (1996)
  • T Uhlig et al.

    Current tobacco smoking, formal education, and the risk of rheumatoid arthritis

    J Rheumatol

    (1999)
  • DP Symmons et al.

    Blood transfusion, smoking, and obesity as risk factors for the development of rheumatoid arthritis: results from a primary care-based incident case-control study in Norfolk, England

    Arthritis Rheum

    (1997)
  • DA Houssien et al.

    Smoking, rheumatoid factors, and rheumatoid arthritis

    Ann Rheum Dis

    (1998)
  • LF Voigt et al.

    Smoking, obesity, alcohol consumption, and the risk of rheumatoid arthritis

    Epidemiology

    (1994)
  • M Heliovaara et al.

    Smoking and risk of rheumatoid arthritis

    J Rheumatol

    (1993)
  • EW Karlson et al.

    A retrospective cohort study of cigarette smoking and risk of rheumatoid arthritis in female health professionals

    Arthritis Rheum

    (1999)
  • BJ Harrison et al.

    The association of cigarette smoking with disease outcome in patients with early inflammatory polyarthritis

    Arthritis Rheum

    (2001)
  • D Hutchinson et al.

    Heavy cigarette smoking is strongly associated with rheumatoid arthritis (RA), particularly in patients without a family history of RA

    Ann Rheum Dis

    (2001)
  • F Chang et al.

    Tumourigenesis associated with the p53 tumour suppressor gene

    Br J Cancer

    (1993)
  • RV Sionov et al.

    Apoptosis by p53: mechanisms, regulation, and clinical implications

    Springer Semin Immunopathol

    (1998)
  • NR Rodrigues et al.

    p53 mutations in colorectal cancer

    Proc Natl Acad Sci U S A

    (1990)
  • AM Davidoff et al.

    Genetic basis for p53 overexpression in human breast cancer

    Proc Natl Acad Sci U S A

    (1991)
  • AG. Knudson

    Antioncogenes and human cancer

    Proc Natl Acad Sci U S A

    (1993)
  • JC Law et al.

    Variation of p53 mutational spectra between carcinoma of the upper and lower respiratory tract

    Clin Cancer Res

    (1995)
  • Cited by (107)

    • Survivin and autoimmunity; the ins and outs

      2018, Immunology Letters
      Citation Excerpt :

      Researches have suggested that environmental factors such as smoking and vitamin D and genetic factors like human leukocyte antigen (HLA) molecules have highly been associated with RA pathogenesis. More than 90% of patients with RA have HLA-DR4 and DW4 antigens [64–67]. Variety of cells, such as lymphocytes, osteoclasts, DCs and synovial fibroblasts (SFs) are involved in RA pathogenesis.

    • Lung disease in rheumatoid arthritis

      2015, Rheumatic Disease Clinics of North America
    View all citing articles on Scopus
    *

    Shirley A. Albano, MD: Fellow, Division of Rheumatology, Cedars-Sinai Medical Center, Los Angeles, CA; Ernesto Santana-Sahagun, MD: Clinical Assistant Professor of Medicine, UCSD School of Medicine, La Jolla, CA; and Michael H. Weisman, MD: Director, Division of Rheumatology, Cedars Sinai Medical Center, Los Angeles, CA, and Professor of Medicine, UCLA School of Medicine, Los Angeles, CA.

    **

    Address reprint requests to Michael H. Weisman, MD, Cedars-Sinai Medical Center, 8700 Beverly Blvd, B-131, Los Angeles, CA 90048. E-mail: [email protected]

    View full text